<?xml version='1.0' encoding='utf-8'?>
<regulation prefix="Regulation" num=".17" citation="COMAR 10.07.05.17" title_num="10" subtitle_num="07" chapter_num="05" heading="Special Requirements for the Provision of Intravenous or Related Therapies.">
  <paragraph num="A.">
    <text>This regulation applies to intravenous or related therapy provided in the home.</text>
  </paragraph>
  <paragraph num="B.">
    <text>A provider of intravenous or related therapies shall meet the requirements of this regulation in addition to meeting the requirements of Regulations .01—.16 of this chapter.</text>
  </paragraph>
  <paragraph num="C.">
    <text>Specialized intravenous therapies and nutritional support services administered enterally or parenterally shall be considered skilled nursing functions.</text>
  </paragraph>
  <paragraph num="D.">
    <text>Medications.</text>
    <paragraph num="(1)">
      <text>Medications and preparations used in the provision of intravenous or nutritional support shall be obtained from a licensed pharmacy.</text>
    </paragraph>
    <paragraph num="(2)">
      <text>The agency shall document any adverse reactions associated with the therapy and notify the client’s physician.</text>
    </paragraph>
  </paragraph>
  <paragraph num="E.">
    <text>Education and Training. When an agency provides intravenous or related therapies, the agency shall provide:</text>
    <paragraph num="(1)">
      <text>Education, training, and written instructions to the client, client representative, or the individual caring for the client before the initiation of treatment, which includes:</text>
      <paragraph num="(a)">
        <text>Feeding formulation or medication preparation;</text>
      </paragraph>
      <paragraph num="(b)">
        <text>Administration of the therapy;</text>
      </paragraph>
      <paragraph num="(c)">
        <text>Accessing private care;</text>
      </paragraph>
      <paragraph num="(d)">
        <text>Equipment maintenance;</text>
      </paragraph>
      <paragraph num="(e)">
        <text>Recognition of complications of therapy, adverse medication reactions, and equipment malfunctions; and</text>
      </paragraph>
      <paragraph num="(f)">
        <text>Mechanisms for accessing a clinician during business hours and at any time after hours for questions related to drug therapy, drug administration, or equipment troubleshooting or malfunctions; and</text>
      </paragraph>
    </paragraph>
    <paragraph num="(2)">
      <text>Retraining and a review to the client, client representative, or the individual caring for the client as needed or requested.</text>
    </paragraph>
  </paragraph>
  <paragraph num="F.">
    <text>The agency shall maintain a clinical record for a client receiving intravenous or related therapies, which, in addition to the documents required to be maintained in accordance with the provisions set forth in Regulations .14 and .15 of this chapter, includes the following:</text>
    <paragraph num="(1)">
      <text>Results of training or retraining of the client, client representative, or the individual caring for the client;</text>
    </paragraph>
    <paragraph num="(2)">
      <text>Composition, indication for use, role, and mode of administration of feeding formulas or medications; and</text>
    </paragraph>
    <paragraph num="(3)">
      <text>Summary statement at termination of the intravenous or related therapy which includes the results of therapy, complications, outcome, and disposition of the client.</text>
    </paragraph>
  </paragraph>
</regulation>